Zolmitriptan
28 NDCs across 13 manufacturers|26 Generic,2 Brand
Zolmitriptan is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 25, 1997, and the first generic was approved May 14, 2013. FDA's Orange Book lists 30 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $8 million on Zolmitriptan across 53,000 claims for 14,000 beneficiaries.
Zolmitriptan is available as 28 NDCs from 13 manufacturers (26 generic, 2 brand), with NADAC prices from $1.02 to $108.89 per EA — the most expensive product costs about 106× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
28
26G / 2B
Manufacturers
13
competing in market
Price Spread
$1.02 – $108.89
per EA
7d Activity
avg +0.5% WoW · of 28 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Glenmark Pharmaceuticals Inc., USA manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
13 manufacturers producing ZOLMITRIPTAN(3 pricing outliers)
Frequently Asked Questions
What is Zolmitriptan used to treat?
Zolmitriptan is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.
When did Zolmitriptan become available as a generic?
FDA approved the first generic Zolmitriptan (ANDA) on May 14, 2013. The Orange Book currently lists 30 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Zolmitriptan?
In 2024, Medicare Part D spent $8 million on Zolmitriptan across 53,000 claims for 14,000 beneficiaries.
How many Zolmitriptan products are on the market?
The Zolmitriptan drug market contains 28 NDCs from 13 manufacturers — 26 generic and 2 brand products.
What is the price range for Zolmitriptan?
NADAC reference prices for Zolmitriptan range from $1.0228 to $108.8863 per EA — the most expensive product costs about 106× the cheapest.
Is generic Zolmitriptan cheaper than brand?
The average generic NADAC for Zolmitriptan is $5.0106 per EA, versus $108.7255 for brand-labeled products — brand versions average about 22× the generic price.
Which manufacturers make Zolmitriptan?
13 manufacturers list Zolmitriptan in NADAC. Ranked by number of NDCs, the largest are Glenmark Pharmaceuticals Inc., USA (4), Alembic Pharmaceuticals Inc. (4), Amneal Pharmaceuticals LLC (2), Jubilant Cadista Pharmaceuticals Inc. (2), Zydus Pharmaceuticals (USA) Inc. (2).
How has the price of Zolmitriptan changed recently?
Over the past 7 days, 12 Zolmitriptan NDCs rose and 10 fell, with a market-wide average change of +0.5%.